Voluntary antenatal HIV testing--results of a pilot study. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Voluntary antenatal HIV testing--results of a pilot study.

CDR (Lond Engl Rev). 1991 Dec 6;1(13):R147-8. Unique Identifier : AIDSLINE MED/94138435
Miller E; Miller CL; Killick SR; Craske J; Waight PA

Abstract: Voluntary testing for antibody to human immunodeficiency virus (HIV) was offered to 4929 antenatal patients attending two hospitals in South Manchester during a 12 month period in 1989/90 in order to assess the feasibility of obtaining seroprevalence data by this method. Of these patients, 1728 (35%) agreed to a named test, 1396 (28%) to an unlinked anonymous test and the remaining 37% declined to be tested. The proportion of women tested increased from 22% to 88% over the period, and was similar in those with and without an identified risk factor for infection. One HIV antibody positive patient was found; she was tested anonymously and had no identified risk. The substantial cost in time and money required to establish the universal voluntary testing programme and the incomplete patient compliance confirm the importance of the unlinked anonymous surveys currently being established in the UK to monitor seroprevalence in sentinel populations.
Keywords: Acquired Immunodeficiency Syndrome/*EPIDEMIOLOGY/TRANSMISSION Adult AIDS Serodiagnosis Cross-Sectional Studies England/EPIDEMIOLOGY Female Human HIV Antibodies/*ANALYSIS HIV Infections/*EPIDEMIOLOGY/TRANSMISSION HIV-1/*IMMUNOLOGY Incidence Infant, Newborn *Mass Screening Pilot Projects *Population Surveillance Pregnancy Pregnancy Complications, Infectious/*EPIDEMIOLOGY *Prenatal Care JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/KWDepidemiology/transmissionadultaidsserodiagnosiscross-sectionalstudiesengland/epidemiologyfemalehumanhivantibodies/KWDanalysishivinfections/KWDepidemiology/transmissionhiv-1/KWDimmunologyincidenceinfant,newbornKWDmassscreeningpilotprojectsKWDpopulationsurveillancepregnancypregnancycomplications,infectious/KWDepidemiologyKWDprenatalcarejournalarticle
940530
M9450878

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .